American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 26,145 | 22,467 | 58,136 | 101,666 | 93,077 |
| Depreciation Amortization | 46,590 | 41,783 | 39,665 | 36,457 | 34,734 |
| Income taxes - deferred | 121 | 2,350 | 11,299 | -18,570 | 5,003 |
| Accounts receivable | -2,624 | 13,118 | 17,568 | -21,221 | -5,987 |
| Accounts payable and accrued liabilities | -9,543 | 25,661 | 2,294 | 8,556 | 519 |
| Other Working Capital | -39,405 | 36,557 | 10,280 | 5,425 | 2,525 |
| Other Operating Activity | 17,537 | -35,532 | -10,694 | 59,893 | 3,724 |
| Operating Cash Flow | $38,821 | $106,404 | $128,548 | $172,206 | $133,595 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13,722 | -42,458 | -33,748 | -61,432 | -46,273 |
| Net Acquisitions | -6,590 | -388 | -1,555 | -4,507 | -2,642 |
| Investing Cash Flow | $-20,312 | $-42,846 | $-35,303 | $-65,939 | $-48,915 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 78,299 | 82,389 | 317,485 | 130,590 | 44,163 |
| Debt Repayment | -54,069 | -90,428 | -327,331 | -275,243 | -24,896 |
| Common Stock Issued | 10 | 1,398 | 2,380 | 175,424 | 851 |
| Common Stock Repurchased | -368 | -838 | N/A | -356 | -193 |
| Dividend Paid | -50 | -332 | -8,729 | -30,241 | N/A |
| Other Financing Activity | -63,137 | -72,058 | -106,344 | -96,518 | -75,092 |
| Financing Cash Flow | $-39,315 | $-79,869 | $-122,539 | $-96,344 | $-55,167 |
| Beginning Cash Position | 55,300 | 71,611 | 100,905 | 90,982 | 61,475 |
| End Cash Position | 34,494 | 55,300 | 71,611 | 100,905 | 90,988 |
| Net Cash Flow | $-20,806 | $-16,311 | $-29,294 | $9,923 | $29,513 |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,821 | 106,404 | 128,548 | 172,206 | 133,595 |
| Capital Expenditure | -23,122 | -44,960 | -36,073 | -61,432 | -46,273 |
| Free Cash Flow | 15,699 | 61,444 | 92,475 | 110,774 | 87,322 |